• <p id="1001x"></p>
  • <pre id="1001x"></pre>
    <table id="1001x"></table>

      FRONTIER BIOTECHNOLOGIES Inc.

      Leadership Team

         
      Home>About
      • Dong Xie, PhD

        Founder, Chairman, CSO
      • CJ Wang, PhD

        Board Director, CEO
      • RJ Lu, PhD

        Board Director, CTO
      • Michelle Zheng PhD

        COO
      • Michael Hu

        CMO
      • Qi Shao

        SVP & CFO
      • Richard Zhao

        SVP BD & Strategy
      • Hangzhou LV

        SVP Mktg. & Sales
      • Cheryl Tan

        Global Head of Intl. Businesses
      • John Zhang PhD

        VP Regulatory Affairs

      Dong Xie, PhD

      Founder, Chairman, CSO

      PhD John Hopkins Univ.

      Executive Director Biocalorimetry Center at John Hopkins; Director Biophysics Lab at National Cancer Institute/NIH

      Global Project Leader and R&D Director at Tibotec (acquired by J&J), led three novel anti-HIV drug development


      CJ Wang, PhD

      Board Director, CEO

      PhD College of Pharmacy, Univ. of Kentucky 

      >20+ years R&D and business development experience in US

      VP BD at Vivus (Nasdaq: VVUS), Abmaxis (acquired by Merck) and TaiGen Biotech; VP Marketing and BD at Cellomics; Director BD and M&A at Packard Bioscience; Principal Scientist at Merck


      RJ Lu, PhD

      Board Director, CTO

      PhD Nankai Univ., Postdoc Northeastern Univ. / Harvard Medical School; Sr. postdoctoral fellow at NCI 

      Principal Research Investigator / Project Leader at Sequoia and Trimeris; Senior Scientist at Tibotec

      Led and participated in CMC development of several anti-HIV drugs including T-20 and Darunavir>


      Michelle Zheng PhD

      COO

      PhD Western Ontario Univ.

      Pharmaceutical executive with 24+ years experience in drug development, CMC, Quality and management at MabPlex, Adellos, Omeros, and AbbVie


      Michael Hu

      CMO

      MD, MS pharmacology, Fudan Univ. Medical School

      20+ years experience in clinical development and medical affairs; Former Head of Medical at Bayer (China)


      Qi Shao

      SVP & CFO

      BS economics Southeastern Univ.  MS Finance Shanghai Univ.

      10+ years experience in finance, auditing, taxation, investment and M&A at BASF and Continental 


      Richard Zhao

      SVP BD & Strategy

      MBA CEIBS; CPD Wharton School, Univ. Penn

      20+ years global BD&MA experience; Former CIO at Fosun Pharma; Global Marketing Dir. at Bayer (US)


      Hangzhou LV

      SVP Mktg. & Sales

      BS Lanzhou Univ., MBA Nanjing Univ.

      20+ years of marketing, sales, and market access experience at Pfizer (China) and Novartis (China)


      Cheryl Tan

      Global Head of Intl. Businesses

      MBA, London School of Economics; Executive Program with Harvard, IMD, INSEAD

      25+years of commercial, general management  experience across Regional (APAC) & Global emerging markets at Sanofi, Abbott and GSK


      John Zhang PhD

      VP Regulatory Affairs

      PhD Peking Univ.

      10+ years drug development experience at Pfizer and Wyeth; 6+ years at US FDA  

      Member of the Quality Guidelines Expert in ICH Technical Requirements at CDE of NMPA


      Develop Innovative Therapies to Better Human Lives

      亚洲电影av-手机版在线播放,最新av影片在线直播在线,手机av看片资源网